Inactive Instrument

Abiomed, Inc.

Equities

ABMD

US0036541003

Advanced Medical Equipment & Technology

Abiomed, Inc. Reports Preliminary Unaudited Revenue Results for the Third Quarter of Fiscal Year 2016

January 11, 2016 at 09:17 pm

Abiomed, Inc. reported preliminary unaudited revenue results for the third quarter of fiscal year 2016. For the quarter, the company reported revenue of approximately $85.8 million, an increase of 38% compared to revenue of $62.0 million for the same period of fiscal 2015.

Latest news about Abiomed, Inc.

Abiomed to Highlight Data Analysis Identifying Complex Clinical Profile of Patients Receiving Impella-Supported HRPCI at TCT Symposium	23/10/23	CI
ABIOMED, Inc. Announces Termination of Todd A. Trapp as Chief Financial Officer	22/12/22	CI
ABIOMED, Inc. Announces Management Changes	22/12/22	CI
ABIOMED, Inc. Announces Termination of Michael R. Minogue as Chief Executive Officer	22/12/22	CI
Johnson & Johnson Closes Acquisition of Abiomed	22/12/22	MT
Abiomed, Inc.(NasdaqGS:ABMD) dropped from NASDAQ Composite Index	22/12/22	CI
Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P 500 Ex-Financials, Real Estate, Utilities and Transportation Index	22/12/22	CI
Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P Global 1200	22/12/22	CI
Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P Healthcare Equipment Select Industry Index	22/12/22	CI
Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P 500 Health Care Equipment & Services (Industry Group)	22/12/22	CI
Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P 500 Health Care Equipment & Supplies	22/12/22	CI
Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P Composite 1500	22/12/22	CI
Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P 500 Health Care	22/12/22	CI
Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P 500 Health Care Equipment (Sub Ind)	22/12/22	CI
Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P 500 Growth	22/12/22	CI
Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P 500	22/12/22	CI
Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P 500 Equal Weighted	22/12/22	CI
Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P TMI Index	22/12/22	CI
Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P Global BMI Index	22/12/22	CI
Johnson & Johnson completed the acquisition of Abiomed, Inc..	21/12/22	CI
Abiomed Says US FDA Approves Impella ECP Pivotal Heart Pump	21/12/22	MT
Abiomed Announces United States Food and Drug Administration Approves Version of Impella ECP	21/12/22	CI
Steel Dynamics to Join S&P 500; Super Micro Computer to be Added to S&P MidCap 400	20/12/22	MT
Johnson & Johnson Extends Abiomed Tender Offer to Dec. 21	14/12/22	MT
Abiomed, Inc.(NasdaqGS:ABMD) dropped from FTSE All-World Index	14/12/22	CI

Chart Abiomed, Inc.

Duration

Period

More charts

Company Profile

Abiomed, Inc. specializes in the development, manufacturing and marketing of medical devices to assist or replace the pumping function of the failing heart. Net sales break down by activity as follows: - sale of products (95.4%): heart pumps (Impella brand); - sale of services (4.6%): including preventive maintenance services. Net sales are distributed geographically as follows: the United States (81.2%), Europe (12.8%), Japan (5%) and other (1%).

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERMO FISHER SCIENTIFIC	+2.06%	207B
DANAHER CORPORATION	+5.69%	181B
INTUITIVE SURGICAL, INC.	+29.31%	155B
SIEMENS HEALTHINEERS AG	+2.36%	64.42B
EDWARDS LIFESCIENCES CORPORATION	+18.36%	54.38B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-1.92%	47.43B
AGILENT TECHNOLOGIES, INC.	-8.37%	37.17B
GE HEALTHCARE TECHNOLOGIES INC.	-1.37%	34.81B
RESMED, INC.	+8.67%	27.46B

Other Advanced Medical Equipment & Technology